- Quantitative molecular analysis in mantle cell lymphoma2011 | Second Faculty of Medicine
- Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network2013 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Use of ibrutinib as "bridging" for allogeneic hematopoietic stem cell transplantation from haploidentic donor and subsequent therapy of residual disease after transplantation in a patient with highly adverse mantle cell lymphoma2019 | First Faculty of Medicine
- Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases2014 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell LymphomaPublication without faculty affiliation
- Treatment of older patients with mantle-cell lymphoma2012 | First Faculty of Medicine
- Diagnosis and therapy of mantle cell lymphoma +12008 | Publication without faculty affiliation
- Mantle Cell Lymphoma - Cutting- edge Dia-gnostics and Treatment Approaches2015 | First Faculty of Medicine
- Refractory mantle cell lymphoma in elderly patient - case report2017 | Faculty of Medicine in Hradec Králové
- PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population2020 | First Faculty of Medicine
- Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma2019 | First Faculty of Medicine
- Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network2013 | First Faculty of Medicine
- Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma2020 | First Faculty of Medicine
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | First Faculty of Medicine, Second Faculty of Medicine
- Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma2018 | Third Faculty of Medicine
- Mantle cell lymphoma: insights into therapeutic targets at the preclinical level2020 | First Faculty of Medicine
- Resistance to TRAIL in mantle cell lymphoma cells is associated with the decreased expression of purine metabolism enzymes2013 | First Faculty of Medicine
- In Vivo Growth of Mantle Cell Lymphoma Xenografts in Immunodeficient Mice Is Positively Regulated by VEGF and Associated with Significant Up-regulation of CD31/PECAM12013 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database2014 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Mantle cell lymphoma with Gaucheroid histiocytesPublication without faculty affiliation
- Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Concurrent tp53 and cdkn2a gene aberrations in newly diagnosed mantle cell lymphoma correlate with chemoresistance and call for innovative upfront therapy2020 | First Faculty of Medicine, Second Faculty of Medicine
- Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma2018 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study2023 | First Faculty of Medicine
- Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference2010 | First Faculty of Medicine
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Cyclin D1 mRNA as a molecular marker for minimal residual disease monitoring in patients with mantle cell lymphoma2018 | First Faculty of Medicine, Second Faculty of Medicine